KCM
CNTB

Kynam Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

Kynam Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-535,005
Closed -$434K – 25
2023
Q3 		$434K Hold
535,005
– – 0.07% 26
2023
Q2 		$603K Sell
535,005
-204,644
-28% -$229K 0.08% 24
2023
Q1 		$740K Hold
739,649
– – 0.1% 32
2022
Q4 		$642K Hold
739,649
– – 0.1% 29
2022
Q3 		$954K Hold
739,649
– – 0.2% 30
2022
Q2 		$643K Buy
739,649
+511,890
+225% +$754K 0.16% 30
2022
Q1 		$688K Buy
+227,759
New +$961K 0.22% 29

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Kynam Capital Management's CNTB Position: Q4 2023 in Review

Kynam Capital Management sold out of Connect Biopharma Holdings (CNTB) in Q4 2023, closing a stake of 535,005 shares — an estimated $434K sold.

Kynam Capital Management first reported a position in CNTB in Q1 2022 and held it in 7 quarters. The position peaked at $954K in Q3 2022. 15 funds tracked by Wall St. Rank hold CNTB as of Q4 2023.

  • Kynam Capital Management reported no remaining Connect Biopharma Holdings position as of Q4 2023 after selling out during the quarter.
  • Kynam Capital Management sold 535,005 Connect Biopharma Holdings shares in Q4 2023, an estimated $434K.
  • Kynam Capital Management first reported a position in Connect Biopharma Holdings in Q1 2022 and held it in 7 quarters.
  • Kynam Capital Management's Connect Biopharma Holdings position peaked at $954K in Q3 2022.
  • 15 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q4 2023.

Based on Kynam Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.